Clinical Trial Update: A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immunogenicity of intramuscular full-dose and intradermal fractional-dose IPV; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Snippet

Sponsor: Fidec Corporation | Conditions: Poliomyelitis | Phase 3 | Status: COMPLETED | Results posted: 2020-08-18